Constant, A. B., Basavaraju, R., France, J., Honig, L. S., Marder, K. S., & Provenzano, F. A. (2022). Longitudinal Patterns of Cortical Atrophy on MRI in Patients With Alzheimer Disease With and Without Lewy Body Pathology. Neurology, 99(17). https://doi.org/10.1212/wnl.0000000000200947

Bhattarai, P., Turgutalp, B., & Kizil, C. (2022). Zebrafish as an Experimental and Preclinical Model for Alzheimer’s Disease. ACS Chemical Neuroscience, 13(20), 2939–2941. https://doi.org/10.1021/acschemneuro.2c00583

Chapman, S., Weiss, D., Broulíková, H. M., Sunderaraman, P., Barker, M. S., Joyce, J. L., Azar, M., McKeague, I., Kriesl, W. C., & Cosentino, S. (2022). Examining the Role of Aging Perceptions in Subjective Cognitive Decline. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/wad.0000000000000518

Casaletto, K. B., Nichols, E., Aslanyan, V., Simone, S. M., Rabin, J. S., La Joie, R., Brickman, A. M., Dams-O’Connor, K., Palta, P., Kumar, R. G., George, K. M., Satizabal, C. L., Schneider, J., & Pa, J. (2022). Sex-specific effects of microglial activation on Alzheimer’s disease proteinopathy in older adults. Brain, 145(10), 3536–3545. https://doi.org/10.1093/brain/awac257

Calcetas, A. T., Thomas, K. R., Edmonds, E. C., Holmqvist, S. L., Edwards, L., Bordyug, M., Delano-Wood, L., Brickman, A. M., Bondi, M. W., Bangen, K. J., & for the Alzheimer’s Disease Neuroimaging Initiative. (2022). Increased regional white matter hyperintensity volume in objectively-defined subtle cognitive decline and mild cognitive impairment. Neurobiology of Aging, 118, 1–8. https://doi.org/10.1016/j.neurobiolaging.2022.06.002

Ming, C., Wang, M., Wang, Q., Neff, R., Wang, E., Shen, Q., Reddy, J. S., Wang, X., Allen, M., Ertekin‐Taner, N., De Jager, P. L., Bennett, D. A., Haroutunian, V., Schadt, E., & Zhang, B. (2021). Whole genome sequencing–based copy number variations reveal novel pathways and targets in Alzheimer’s disease. Alzheimer’s & Dementia, 18(10), 1846–1867. Portico. https://doi.org/10.1002/alz.12507

Silverman, W., Krinsky‐McHale, S. J., Zigman, W. B., & Schupf, N. (2021). Adults with Down syndrome in randomized clinical trials targeting prevention of Alzheimer’s disease. Alzheimer’s & Dementia, 18(10), 1736–1743. Portico. https://doi.org/10.1002/alz.12520

Iqbal, J., Suarez, M. D., Yadav, P. K., Walsh, M. T., Li, Y., Wu, Y., Huang, Z., James, A. W., Escobar, V., Mokbe, A., Brickman, A. M., Luchsinger, J. A., Dai, K., Moreno, H., & Hussain, M. M. (2022). ATP-binding cassette protein ABCA7 deficiency impairs sphingomyelin synthesis, cognitive discrimination, and synaptic plasticity in the entorhinal cortex. Journal of Biological Chemistry, 298(10), 102411. https://doi.org/10.1016/j.jbc.2022.102411

Seto, M., Weiner, R. L., Dumitrescu, L., Mahoney, E. R., Hansen, S. L., Janve, V., Khan, O. A., Liu, D., Wang, Y., Menon, V., De Jager, P. L., Schneider, J. A., Bennett, D. A., Gifford, K. A., Jefferson, A. L., & Hohman, T. J. (2022). RNASE6 is a novel modifier of APOE-ε4 effects on cognition. Neurobiology of Aging, 118, 66–76. https://doi.org/10.1016/j.neurobiolaging.2022.06.011

Buckles, V. D., Xiong, C., Bateman, R. J., Hassenstab, J., Allegri, R., Berman, S. B., Chhatwal, J. P., Danek, A., Fagan, A. M., Ghetti, B., Goate, A., Graff‐Radford, N., Jucker, M., Levin, J., Marcus, D. S., Masters, C. L., McCue, L., McDade, E., … Mori, H. (2021). Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer disease. Alzheimer’s & Dementia, 18(10), 1754–1764. Portico. https://doi.org/10.1002/alz.12505

Morris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., Cairns, N. J., Carrillo, M. C., Chui, H. C., Chhatwal, J. P., Cruchaga, C., Fagan, A. M., Farlow, M., Fox, N. C., Ghetti, B., … Buckles, V. D. (2022). Autosomal dominant and sporadic late onset Alzheimer’s disease share a commonin vivopathophysiology. Brain, 145(10), 3594–3607. https://doi.org/10.1093/brain/awac181

Gao, Y., Felsky, D., Reyes‐Dumeyer, D., Sariya, S., Rentería, M. A., Ma, Y., Klein, H., Cosentino, S., De Jager, P. L., Bennett, D. A., Brickman, A. M., Schellenberg, G. D., Mayeux, R., & Barral, S. (2021). Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance. Alzheimer’s & Dementia, 18(10), 1797–1811. Portico. https://doi.org/10.1002/alz.12524

Moni, F., Petersen, M. E., Zhang, F., Lao, P. J., Zimmerman, M. E., Gu, Y., Gutierrez, J., Rizvi, B., Laing, K. K., Igwe, K. C., Sathishkumar, M., Keator, D., Andrews, H., Krinsky‐McHale, S., Head, E., Lee, J. H., Lai, F., Yassa, M. A., Rosas, H. D., … Brickman, A. M. (2022). Probing the proteome to explore potential correlates of increased Alzheimer’s‐related cerebrovascular disease in adults with Down syndrome. Alzheimer’s & Dementia, 18(10), 1744–1753. Portico. https://doi.org/10.1002/alz.12627

Sugden, K., Caspi, A., Elliott, M. L., Bourassa, K. J., Chamarti, K., Corcoran, D. L., Hariri, A. R., Houts, R. M., Kothari, M., Kritchevsky, S., Kuchel, G. A., Mill, J. S., Williams, B. S., Belsky, D. W., & Moffitt, T. E. (2022). Association of Pace of Aging Measured by Blood-Based DNA Methylation With Age-Related Cognitive Impairment and Dementia. Neurology, 99(13). https://doi.org/10.1212/wnl.0000000000200898

Turgutalp, B., Bhattarai, P., Ercetin, T., Luise, C., Reis, R., Gurdal, E. E., Isaak, A., Biriken, D., Dinter, E., Sipahi, H., Schepmann, D., Junker, A., Wünsch, B., Sippl, W., Gulcan, H. O., Kizil, C., & Yarim, M. (2022). Discovery of Potent Cholinesterase Inhibition-Based Multi-Target-Directed Lead Compounds for Synaptoprotection in Alzheimer’s Disease. Journal of Medicinal Chemistry, 65(18), 12292–12318. https://doi.org/10.1021/acs.jmedchem.2c01003

Mishra, R., Phan, T., Kumar, P., Morrissey, Z., Gupta, M., Hollands, C., Shetti, A., Lopez, K. L., Maienschein-Cline, M., Suh, H., Hen, R., & Lazarov, O. (2022). Augmenting neurogenesis rescues memory impairments in Alzheimer’s disease by restoring the memory-storing neurons. Journal of Experimental Medicine, 219(9). https://doi.org/10.1084/jem.20220391

Lao, P. J., Boehme, A. K., Morales, C., Laing, K. K., Chesebro, A., Igwe, K. C., Gutierrez, J., Gu, Y., Stern, Y., Schupf, N., Manly, J. J., Mayeux, R., & Brickman, A. M. (2022). Amyloid, cerebrovascular disease, and neurodegeneration biomarkers are associated with cognitive trajectories in a racially and ethnically diverse, community-based sample. Neurobiology of Aging, 117, 83–96. https://doi.org/10.1016/j.neurobiolaging.2022.05.004

Heavener, K. S., & Bradshaw, E. M. (2022). The aging immune system in Alzheimer’s and Parkinson’s diseases. Seminars in Immunopathology, 44(5), 649–657. https://doi.org/10.1007/s00281-022-00944-6

Adkins-Jackson, P. B., & Belsky, D. W. (2022). Alzheimer’s disease risk biomarkers: progress and challenges. The Lancet Healthy Longevity, 3(9), e575–e576. https://doi.org/10.1016/s2666-7568(22)00191-x

Zhu, X., Liu, Y., Habeck, C. G., Stern, Y., Lee, S., & for-the-Alzheimer’s-Disease-Neuroimaging-Initiative. (2022). Transfer learning for cognitive reserve quantification. NeuroImage, 258, 119353. https://doi.org/10.1016/j.neuroimage.2022.119353

Sun, J., Ludvigsson, J. F., Ingre, C., Piehl, F., Wirdefeldt, K., Zagai, U., Ye, W., & Fang, F. (2022). Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden. PLOS Medicine, 19(9), e1004092. https://doi.org/10.1371/journal.pmed.1004092

Crotty, G. F., Keavney, J. L., Alcalay, R. N., Marek, K., Marshall, G. A., Rosas, H. D., & Schwarzschild, M. A. (2022). Planning for Prevention of Parkinson Disease. Neurology, 99(7_Supplement_1), 1–9. https://doi.org/10.1212/wnl.0000000000200789

Tahami Monfared, A. A., Stern, Y., Doogan, S., Irizarry, M., & Zhang, Q. (2022). Stakeholder Insights in Alzheimer’s Disease: Natural Language Processing of Social Media Conversations. Journal of Alzheimer’s Disease, 89(2), 695–708. https://doi.org/10.3233/jad-220422

Du, F., Yu, Q., Kanaan, N. M., & Yan, S. S. (2022). Mitochondrial oxidative stress contributes to the pathological aggregation and accumulation of tau oligomers in Alzheimer’s disease. Human Molecular Genetics, 31(15), 2498–2507. https://doi.org/10.1093/hmg/ddab363

Janelidze, S., Christian, B. T., Price, J., Laymon, C., Schupf, N., Klunk, W. E., Lott, I., Silverman, W., Rosas, H. D., Zaman, S., Mapstone, M., Lai, F., Ances, B. M., Handen, B. L., & Hansson, O. (2022). Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers. JAMA Neurology, 79(8), 797. https://doi.org/10.1001/jamaneurol.2022.1740

Rabin, J. S., Nichols, E., La Joie, R., Casaletto, K. B., Palta, P., Dams-O’Connor, K., Kumar, R. G., George, K. M., Satizabal, C. L., Schneider, J. A., Pa, J., & Brickman, A. M. (2022). Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain, 145(8), 2823–2833. https://doi.org/10.1093/brain/awac178

Kamath, V., Senjem, M. L., Spychalla, A. J., Chen, H., Palta, P., Mosley, T. H., Windham, B. G., Griswold, M., Knopman, D. S., Gottesman, R. F., Jack, C. R., Sharrett, A. R., & Schneider, A. L. C. (2022). The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment. Journal of Alzheimer’s Disease, 89(1), 233–245. https://doi.org/10.3233/jad-220228

Rajabli, F., Beecham, G. W., Hendrie, H. C., Baiyewu, O., Ogunniyi, A., Gao, S., Kushch, N. A., Lipkin-Vasquez, M., Hamilton-Nelson, K. L., Young, J. I., Dykxhoorn, D. M., Nuytemans, K., Kunkle, B. W., Wang, L., Jin, F., Liu, X., Feliciano-Astacio, B. E., Schellenberg, G. D., … Vance, J. M. (2022). A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s Disease in African Ancestry. PLOS Genetics, 18(7), e1009977. https://doi.org/10.1371/journal.pgen.1009977

Peris, L., Parato, J., Qu, X., Soleilhac, J. M., Lanté, F., Kumar, A., Pero, M. E., Martínez-Hernández, J., Corrao, C., Falivelli, G., Payet, F., Gory-Fauré, S., Bosc, C., Blanca Ramirez, M., Sproul, A., Brocard, J., Di Cara, B., Delagrange, P., Buisson, A., … Andrieux, A. (2022). Tubulin tyrosination regulates synaptic function and is disrupted in Alzheimer’s disease. Brain, 145(7), 2486–2506. https://doi.org/10.1093/brain/awab436

Lee, A. J., Raghavan, N. S., Bhattarai, P., Siddiqui, T., Sariya, S., Reyes-Dumeyer, D., Flowers, X. E., Cardoso, S. A. L., De Jager, P. L., Bennett, D. A., Schneider, J. A., Menon, V., Wang, Y., Lantigua, R. A., Medrano, M., Rivera, D., Jiménez-Velázquez, I. Z., Kukull, W. A., Brickman, A. M., … Mayeux, R. (2022). FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease. Acta Neuropathologica, 144(1), 59–79. https://doi.org/10.1007/s00401-022-02431-6

Eissman, J. M., Dumitrescu, L., Mahoney, E. R., Smith, A. N., Mukherjee, S., Lee, M. L., Scollard, P., Choi, S. E., Bush, W. S., Engelman, C. D., Lu, Q., Fardo, D. W., Trittschuh, E. H., Mez, J., Kaczorowski, C. C., Hernandez Saucedo, H., Widaman, K. F., Buckley, R. F., Properzi, M. J., … Hohman, T. J. (2022). Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease. Brain, 145(7), 2541–2554. https://doi.org/10.1093/brain/awac177

Goldman, J. E. (2022). Alzheimer Type I Astrocytes: Still Mysterious Cells. Journal of Neuropathology & Experimental Neurology, 81(8), 588–595. https://doi.org/10.1093/jnen/nlac043

Cosacak, M. I., Bhattarai, P., De Jager, P. L., Menon, V., Tosto, G., & Kizil, C. (2022). Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease. Cells, 11(11), 1807. https://doi.org/10.3390/cells11111807

Haage, V., & De Jager, P. L. (2022). Neuroimmune contributions to Alzheimer’s disease: a focus on human data. Molecular Psychiatry, 27(8), 3164–3181. https://doi.org/10.1038/s41380-022-01637-0

Kumar, J. S. D., Molotkov, A., Kim, J., Carberry, P., Idumonyi, S., Castrillon, J., Duff, K., Shneider, N. A., & Mintz, A. (2022). Preclinical evaluation of a microtubule PET ligand [11C]MPC-6827 in tau and amyotrophic lateral sclerosis animal models. Pharmacological Reports, 74(3), 539–544. https://doi.org/10.1007/s43440-022-00359-y

Kizil, C., Sariya, S., Kim, Y. A., Rajabli, F., Martin, E., Reyes-Dumeyer, D., Vardarajan, B., Maldonado, A., Haines, J. L., Mayeux, R., Jiménez-Velázquez, I. Z., Santa-Maria, I., & Tosto, G. (2022). Admixture Mapping of Alzheimer’s disease in Caribbean Hispanics identifies a new locus on 22q13.1. Molecular Psychiatry, 27(6), 2813–2820. https://doi.org/10.1038/s41380-022-01526-6

Gu, Y., Kociolek, A., Fernandez, K. K., Cosentino, S. A., Zhu, C. W., Jin, Z., Leverenz, J. B., & Stern, Y. B. (2022). Clinical Trajectories at the End of Life in Autopsy-Confirmed Dementia Patients With Alzheimer Disease and Lewy Bodies Pathologies. Neurology, 98(21). https://doi.org/10.1212/wnl.0000000000200259

Tsiakiri, A., Koutzmpi, V., Megagianni, S., Toumaian, M., Geronikola, N., Despoti, A., Kanellopoulou, S., Arampatzi, X., Margioti, E., Davila, A., Zoi, P., Kalligerou, F., Liozidou, A., Tsapanou, A., & Sakka, P. (2022). Remote neuropsychological evaluation of older adults. Applied Neuropsychology: Adult, 31(5), 796–803. https://doi.org/10.1080/23279095.2022.2074850

Kim, H., Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., & Goldberg, T. E. (2022). The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer’s Disease Risks. Journal of Alzheimer’s Disease, 87(4), 1567–1580. https://doi.org/10.3233/jad-215417

Reiken, S., Sittenfeld, L., Dridi, H., Liu, Y., Liu, X., & Marks, A. R. (2022). Alzheimer’s‐like signaling in brains of COVID‐19 patients. Alzheimer’s & Dementia, 18(5), 955–965. Portico. https://doi.org/10.1002/alz.12558

Chen, S., Acosta, D., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C., Goulbourne, C. N., Nakano, Y., Villegas, N. C. H., Venkataraman, L., Brown, C., Serrano, G. E., Bell, E., Wemlinger, T., Wu, M., Kokiko-Cochran, O. N., Popovich, P., … Fu, H. (2022). Wolframin is a novel regulator of tau pathology and neurodegeneration. Acta Neuropathologica, 143(5), 547–569. https://doi.org/10.1007/s00401-022-02417-4

Brickman, A. M., Manly, J. J., Honig, L. S., Sanchez, D., Reyes‐Dumeyer, D., Lantigua, R. A., Vonsattel, J. P., Teich, A. F., Kang, M. S., Dage, J. L., & Mayeux, R. (2022). Correlation of plasma and neuroimaging biomarkers in Alzheimer’s disease. Annals of Clinical and Translational Neurology, 9(5), 756–761. Portico. https://doi.org/10.1002/acn3.51529

Younan, D., Wang, X., Gruenewald, T., Gatz, M., Serre, M. L., Vizuete, W., Braskie, M. N., Woods, N. F., Kahe, K., Garcia, L., Lurmann, F., Manson, J. E., Chui, H. C., Wallace, R. B., Espeland, M. A., & Chen, J.-C. (2021). Racial/Ethnic Disparities in Alzheimer’s Disease Risk: Role of Exposure to Ambient Fine Particles. The Journals of Gerontology: Series A, 77(5), 977–985. https://doi.org/10.1093/gerona/glab231

Guisle, I., Canet, G., Pétry, S., Fereydouni-Forouzandeh, P., Morin, F., Kérauden, R., Whittington, R. A., Calon, F., Hébert, S. S., & Planel, E. (2022). Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia. Neurobiology of Aging, 113, 118–130. https://doi.org/10.1016/j.neurobiolaging.2022.02.011

Rippon, B., Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., & Luchsinger, J. A. (2022). Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics. Journal of Alzheimer’s Disease, 87(3), 1229–1238. https://doi.org/10.3233/jad-210391

Libon, D. J., Swenson, R., Lamar, M., Price, C. C., Baliga, G., Pascual-Leone, A., Au, R., Cosentino, S., & Andersen, S. L. (2022). The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions. Journal of Alzheimer’s Disease, 87(4), 1419–1432. https://doi.org/10.3233/jad-220096

Devanand, D. P., Lee, S., Huey, E. D., & Goldberg, T. E. (2022). Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias. JAMA Psychiatry, 79(4), 359. https://doi.org/10.1001/jamapsychiatry.2021.4363

Ma, Y., Yu, L., Olah, M., Smith, R., Oatman, S. R., Allen, M., Pishva, E., Zhang, B., Menon, V., Ertekin‐Taner, N., Lunnon, K., Bennett, D. A., Klein, H., & De Jager, P. L. (2021). Epigenomic features related to microglia are associated with attenuated effect ofAPOEε4 on Alzheimer’s disease risk in humans. Alzheimer’s & Dementia, 18(4), 688–699. Portico. https://doi.org/10.1002/alz.12425

Barker, M. S., Gottesman, R. T., Manoochehri, M., Chapman, S., Appleby, B. S., Brushaber, D., Devick, K. L., Dickerson, B. C., Domoto-Reilly, K., Fields, J. A., Forsberg, L. K., Galasko, D. R., Ghoshal, N., Goldman, J., Graff-Radford, N. R., Grossman, M., Heuer, H. W., Hsiung, G.-Y., Knopman, D. S., … Weintraub, S. (2022). Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain, 145(3), 1079–1097. https://doi.org/10.1093/brain/awab365

Neuner, S. M., Telpoukhovskaia, M., Menon, V., O’Connell, K. M. S., Hohman, T. J., & Kaczorowski, C. C. (2022). Translational approaches to understanding resilience to Alzheimer’s disease. Trends in Neurosciences, 45(5), 369–383. https://doi.org/10.1016/j.tins.2022.02.005